0

Global Regenerative Medicine Market by Technology and Geography - Forecast and Analysis 2022-2026

  • Published: May 2022
  • Pages: 138
  • SKU: IRTNTR41171
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

Based on Technavio's market sizing methodology, the regenerative medicines market size is predicted to surge by USD 28.67 billion from 2021 to 2026 at a CAGR of 14.57%.

This regenerative medicines market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. The regenerative medicines market report offers information on several market vendors, including AbbVie Inc., Amgen Inc., Baxter International Inc., Becton Dickinson and Co., Cook Group Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Integra LifeSciences Corp., Johnson and Johnson, Medtronic Plc, Merck and Co. Inc., Mesoblast Ltd., MiMedx Group Inc., Novartis AG, Nuvasive Inc., Organogenesis Inc., Smith and Nephew plc, Thermo Fisher Scientific Inc., Vericel Corp., and Zimmer Biomet Holdings Inc. among others.

This report further entails regenerative medicines market segmentations, including:

  • Technology - Cell and tissue-based and Gene therapy 
  • Geography - North America, Europe, Asia, and Rest of World (ROW)

What will the Regenerative Medicines Market Size be During the Forecast Period?

Global Regenerative Medicine Market Size

Download the Free Report Sample to Unlock the Regenerative Medicines Market Size for the Forecast Period and Other Important Statistics

 

Regenerative Medicines Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The increasing prevalence of chronic diseases is notably driving the regenerative medicines market growth, although factors such as uncertain regulatory approval may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the regenerative medicines industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Regenerative Medicines Market Driver

  • The increasing prevalence of chronic diseases is one of the key drivers fueling the regenerative medicines market growth.
  • Chronic wounds are a significant burden on patients, healthcare professionals, and healthcare systems. It is estimated that chronic wounds affect approximately six million patients in the US every year annually.
  • Most chronic diseases may result in tissue or organ damage and treatments available for them are palliative.
  • Regenerative medicine opens the possibility of overcoming previously untreatable diseases using new treatment methods such as processed cells for reconstructing tissues.
  • Regenerative medicine helps in reducing healthcare costs by eliminating the need for long-term hospitalization or drug regimes. This is leading to the increased adoption of regenerative medicine for the treatment of chronic diseases, which, in turn, is driving the market growth.

Key Regenerative Medicines Market Trend

  • The increasing number of clinical trials is one of the key regenerative medicines market trends supporting the market growth.
  • The increasing initiatives and support from various international and national public and private organizations have led to an increase in the number of clinical trials.
  • Many vendors are focusing on geographical extensions and indication extensions for their approved products. 
  • The significant rise in the number of clinical trials indicates the increasing focus of vendors on the R&D of regenerative medicine.
  • Few products in late-stage (Phase III) clinical trials are expected to enter the market during the forecast period and drive the growth of the global regenerative medicine market.

Key Regenerative Medicines Market Challenge

  • Uncertain regulatory approval is one of the challenges limiting the regenerative medicines market growth.
  • Gene therapy, cell therapy, and tissue engineering have been under development for several decades. However, their successful clinical application is still considered to be a recent phenomenon in both developed and developing countries.
  • Sometimes, it takes years to understand the clinical impact of some regenerative products.
  • Stringent regulations and uncertainty about regulatory approval of regenerative medicine products pose a significant challenge for the vendors operating in the market.
  • Regenerative medicine products have to undergo a broad range of stringent regulations before approval and commercialization. This, in turn, will limit the regenerative medicines market growth during the forecast period.

This regenerative medicines market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global regenerative medicines market as a part of the pharmaceutical market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the regenerative medicines market during the forecast period.

Who are the Major Regenerative Medicines Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • AbbVie Inc.
  • Amgen Inc.
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • Cook Group Inc.
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • Integra LifeSciences Corp.
  • Johnson and Johnson
  • Medtronic Plc
  • Merck and Co. Inc.
  • Mesoblast Ltd.
  • MiMedx Group Inc.
  • Novartis AG
  • Nuvasive Inc.
  • Organogenesis Inc.
  • Smith and Nephew plc
  • Thermo Fisher Scientific Inc.
  • Vericel Corp.
  • Zimmer Biomet Holdings Inc.

 

This statistical study of the regenerative medicines market encompasses successful business strategies deployed by the key vendors. The regenerative medicines market is fragmented and the vendors are deploying organic and inorgnaic growth strategies to compete in the market.

Product Insights and News

  • Abbvie.com - The company offers regenerative medicines such as ALLODERM SELECT and ALLODERM.
  • Baxter.com - The company offers regenerative medicines such as 0600065PR EASYSPRAY Set with EASYSPRAY Pressure Regulator.
  • Bd.com - The company offers regenerative medicines through its stem cells and stem cell niches.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The regenerative medicines market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Regenerative Medicines Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the regenerative medicines market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Regenerative Medicines Market?

Global Regenerative Medicine Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

45% of the market's growth will originate from North America during the forecast period. The US is the key market for regenerative medicines market in North America. Market growth in this region will be slower than the growth of the market in other regions.

The increasing prevalence of chronic and acute diseases will facilitate the regenerative medicines market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 in 2020 had a negative impact on the regional market. However, regenerative medicines have been found to have potential uses in the treatment of COVID-19, as they aim at repairing, regenerating, and restoring the missing functions of organ cells. Thus, studying the interactions between the virus and host cells can be beneficial, and the regional regenerative medicines market will likely register growth during the forecast period.

What are the Revenue-generating Technology Segments in the Regenerative Medicines Market?

Global Regenerative Medicine Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The regenerative medicines market share growth by the cell and tissue-based segment will be significant during the forecast period. The cell and tissue-based therapies are opted for by individuals who can afford expensive therapies and are looking for a permanent and specific cure for a disease. Moreover, the approval of various new tissue-engineered regenerative medicine products and the increasing focus of companies on R&D to develop new cell and tissue-based therapies are anticipated to drive the cell and tissue-based therapy segment during the forecast period. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the regenerative medicines market size and actionable market insights on post COVID-19 impact on each segment.

 

Regenerative Medicines Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 14.57%

Market growth 2022-2026

$ 28.67 billion

Market structure

Fragmented

YoY growth (%)

13.07

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 45%

Key consumer countries

US, Germany, UK, Japan, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

AbbVie Inc., Amgen Inc., Baxter International Inc., Becton Dickinson and Co., Cook Group Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Integra LifeSciences Corp., Johnson and Johnson, Medtronic Plc, Merck and Co. Inc., Mesoblast Ltd., MiMedx Group Inc., Novartis AG, Nuvasive Inc., Organogenesis Inc., Smith and Nephew plc, Thermo Fisher Scientific Inc., Vericel Corp., and Zimmer Biomet Holdings Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Regenerative Medicines Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive regenerative medicines market growth during the next five years
  • Precise estimation of the regenerative medicines market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the regenerative medicines industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of regenerative medicines market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Technology

    • 5.1 Market segments
      • Exhibit 24: Chart on Technology - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Technology - Market share 2021-2026 (%)
    • 5.2 Comparison by Technology
      • Exhibit 26: Chart on Comparison by Technology
      • Exhibit 27: Data Table on Comparison by Technology
    • 5.3 Cell and tissue-based - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Cell and tissue-based - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Cell and tissue-based - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Cell and tissue-based - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Cell and tissue-based - Year-over-year growth 2021-2026 (%)
    • 5.4 Gene therapy - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by Technology
      • Exhibit 36: Market opportunity by Technology ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 40: Chart on Geographic comparison
      • Exhibit 41: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 Japan - Market size and forecast 2021-2026
      • Exhibit 66: Chart on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on Japan - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
    • 7.10 UK - Market size and forecast 2021-2026
      • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.11 China - Market size and forecast 2021-2026
      • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 78: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 81: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 82: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 83: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 84: Matrix on vendor position and classification
            • 10.3 AbbVie Inc.
              • Exhibit 85: AbbVie Inc. - Overview
              • Exhibit 86: AbbVie Inc. - Product / Service
              • Exhibit 87: AbbVie Inc. - Key offerings
            • 10.4 Baxter International Inc.
              • Exhibit 88: Baxter International Inc. - Overview
              • Exhibit 89: Baxter International Inc. - Business segments
              • Exhibit 90: Baxter International Inc. - Key news
              • Exhibit 91: Baxter International Inc. - Key offerings
              • Exhibit 92: Baxter International Inc. - Segment focus
            • 10.5 Becton Dickinson and Co.
              • Exhibit 93: Becton Dickinson and Co. - Overview
              • Exhibit 94: Becton Dickinson and Co. - Business segments
              • Exhibit 95: Becton Dickinson and Co. - Key news
              • Exhibit 96: Becton Dickinson and Co. - Key offerings
              • Exhibit 97: Becton Dickinson and Co. - Segment focus
            • 10.6 Cook Group Inc.
              • Exhibit 98: Cook Group Inc. - Overview
              • Exhibit 99: Cook Group Inc. - Product / Service
              • Exhibit 100: Cook Group Inc. - Key offerings
            • 10.7 Integra LifeSciences Corp.
              • Exhibit 101: Integra LifeSciences Corp. - Overview
              • Exhibit 102: Integra LifeSciences Corp. - Business segments
              • Exhibit 103: Integra LifeSciences Corp. - Key news
              • Exhibit 104: Integra LifeSciences Corp. - Key offerings
              • Exhibit 105: Integra LifeSciences Corp. - Segment focus
            • 10.8 Medtronic Plc
              • Exhibit 106: Medtronic Plc - Overview
              • Exhibit 107: Medtronic Plc - Business segments
              • Exhibit 108: Medtronic Plc - Key news
              • Exhibit 109: Medtronic Plc - Key offerings
              • Exhibit 110: Medtronic Plc - Segment focus
            • 10.9 Merck and Co. Inc.
              • Exhibit 111: Merck and Co. Inc. - Overview
              • Exhibit 112: Merck and Co. Inc. - Business segments
              • Exhibit 113: Merck and Co. Inc. - Key news
              • Exhibit 114: Merck and Co. Inc. - Key offerings
              • Exhibit 115: Merck and Co. Inc. - Segment focus
            • 10.10 Organogenesis Inc.
              • Exhibit 116: Organogenesis Inc. - Overview
              • Exhibit 117: Organogenesis Inc. - Product / Service
              • Exhibit 118: Organogenesis Inc. - Key offerings
            • 10.11 Smith and Nephew plc
              • Exhibit 119: Smith and Nephew plc - Overview
              • Exhibit 120: Smith and Nephew plc - Business segments
              • Exhibit 121: Smith and Nephew plc - Key news
              • Exhibit 122: Smith and Nephew plc - Key offerings
              • Exhibit 123: Smith and Nephew plc - Segment focus
            • 10.12 Thermo Fisher Scientific Inc.
              • Exhibit 124: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 125: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 126: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 127: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 128: Thermo Fisher Scientific Inc. - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 129: Inclusions checklist
                • Exhibit 130: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 131: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 132: Research methodology
                • Exhibit 133: Validation techniques employed for market sizing
                • Exhibit 134: Information sources
              • 11.5 List of abbreviations
                • Exhibit 135: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Regenerative Medicines market growth will increase by $28673.11 million during 2022-2026.
              The regenerative medicines market is expected to grow at a CAGR of 14.57% during 2022-2026.
              Technavio has segmented the regenerative medicines market by technology (Cell and tissue-based and Gene therapy) and geographic (North America, Europe, Asia, and Rest of World (ROW)).
              AbbVie Inc., Amgen Inc., Baxter International Inc., Becton Dickinson and Co., Cook Group Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Integra LifeSciences Corp., Johnson and Johnson, Medtronic Plc, Merck and Co. Inc., Mesoblast Ltd., MiMedx Group Inc., Novartis AG, Nuvasive Inc., Organogenesis Inc., Smith and Nephew plc, Thermo Fisher Scientific Inc., Vericel Corp., Zimmer Biomet Holdings Inc. are a few of the key vendors in the regenerative medicines market.
              North America will register the highest growth rate of 45.4% among the other regions. Therefore, the regenerative medicines market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the regenerative medicines market growth are:
              • Increasing prevalence of chronic diseases
              • Increasing number of clinical trials
              The regenerative medicines market vendors should focus on grabbing business opportunities from the cell and tissue-based segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single User:

                Quick and easy buy and download option

              • Enterprise:

                Flexible option - Complimentary customization included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>